Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.

@article{Ostrowski2007PharmacologicalAX,
  title={Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.},
  author={Jacek C. Ostrowski and Joyce E Kuhns and John A. Lupisella and Mark C. Manfredi and Blake C. Beehler and Stanley R. Krystek and Yingzhi Bi and Chongqing East Windsor Sun and Ramakrishna Seethala and Rajasree Golla and Paul G. Sleph and Aberra Fura and Yongmi An and Kevin Francis Patrick Kish and John S. Sack and Kasim A. Mookhtiar and Gary James Grover and Lawrence Gerard Hamann},
  journal={Endocrinology},
  year={2007},
  volume={148 1},
  pages={
          4-12
        }
}
A novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator (BMS-564929) has been identified, and this compound has been advanced to clinical trials for the treatment of age-related functional decline. BMS-564929 is a subnanomolar AR agonist in vitro, is highly selective for the AR vs. other steroid hormone receptors, and exhibits no significant interactions with SHBG or aromatase. Dose response studies in castrated male rats show that BMS-564929 is… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

Deciphering the selective androgen receptor modulators paradigm.

  • Expert opinion on drug discovery
  • 2013
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Sex hormones, aging, and Alzheimer's disease.

  • Frontiers in bioscience
  • 2012
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers

Loading similar papers…